Wrest wing: the bid to oust Trump
The Intelligence from The Economist
00:00
Breakthroughs in COVID-19 Treatments
This chapter examines the healthcare crisis in the U.S. during the COVID-19 pandemic, focusing on the strain on hospitals and promising clinical trial results for two arthritis drugs. It highlights the potential of tocilizumab and cerilumab in reducing mortality rates and improving recovery times for severely ill patients, while addressing the economic implications of these treatments.
Transcript
Play full episode
